Redcare Pharmacy Sees FY Total Group Sales Of EUR 2.35 To EUR 2.5 Billion

T-Reuters
2024/10/04

Redcare Pharmacy NV :Eqs-Adhoc: Redcare Pharmacy Achieves 81% Growth In Q3 Rx Sales In Germany, 108% In September And Decides To Accelerate Marketing In Q4 Based On Very Convincing E-Rx Metrics. Full-Year Guidance Updated..Redcare Pharmacy Nv Sees Fy Total Group Sales Of Eur 2.35 To Eur 2.5 Billion (Previously, Eur 2.3 To Eur 2.5 Billion).Redcare Pharmacy Nv- Sees Fy Adjusted Ebitda Margin Of 1.2-2.2% (Previously 2-4%).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10